Comparing effects of BK virus agnoprotein and herpes simplex-1 ICP47 on MHC-I and MHC-II expression

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Cioni, Michela ^a   Mittelholzer, Christian ^a   Wernli, Marion ^a   Hirsch, Hans H ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGNOPROTEIN; CHROMIUM 51; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TETRACYCLINE; AGNOPROTEIN, POLYOMAVIRUS; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; ICP47 PROTEIN, HERPES SIMPLEX VIRUS; IMMEDIATE EARLY PROTEIN; VIRUS PROTEIN;

ARTICLE; BK VIRUS; COMPARATIVE STUDY; CYTOTOXICITY; DOSE RESPONSE; DOWN REGULATION; FLOW CYTOMETRY; HERPES SIMPLEX; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; NONHUMAN; PLASMID; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; CELL SEPARATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; POLYOMAVIRUS INFECTION; SIMPLEXVIRUS; TRANSGENE; TUMOR CELL LINE; VIRAL PHENOMENA AND FUNCTIONS; VIROLOGY; VIRUS INFECTION;

BK VIRUS; CELL LINE, TUMOR; CELL SEPARATION; EPITHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; IMMEDIATE-EARLY PROTEINS; POLYOMAVIRUS INFECTIONS; SIMPLEXVIRUS; TRANSGENES; TUMOR VIRUS INFECTIONS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS PHYSIOLOGICAL PROCESSES;

MLCS; MLOWN;

EID: 84876529093     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/626823     Document Type: Article

References (25)

1. Kean J. M., Rao S., Wang M., Garcea R. L., Seroepidemiology of human polyomaviruses. PLoS Pathogens 2009 5 3 e1000363 2-s2.0-63449123993 10.1371/journal.ppat.1000363
2. Nguyen N. L., Le B. M., Wang D., Serologic evidence of frequent human infection with WU and KI polyomaviruses. Emerging Infectious Diseases 2009 15 8 1199 1205 2-s2.0-68049115674 10.3201/eid1508.090270
3. Egli A., Infanti L., Dumoulin A., Buser A., Samaridis J., Stebler C., Gosert R., Hirsch H. H., Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. Journal of Infectious Diseases 2009 199 6 837 846 2-s2.0-65649099693 10.1086/597126
4. Schowalter R. M., Pastrana D. V., Pumphrey K. A., Moyer A. L., Buck C. B., Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host and Microbe 2010 7 6 509 515 2-s2.0-77956506650 10.1016/j.chom.2010.05.006
5. Knowles W. A., Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Advances in Experimental Medicine and Biology 2006 577 19 45 2-s2.0-33745630722 10.1007/0-387-32957-9-2
6. Dalianis T., Hirsch H. H., Human polyomaviruses in disease and cancer. Virology 2013 437 2 63 72 10.1016/j.virol.2012.12.015
7. Dalianis T., Ramqvist T., Andreasson K., Kean J. M., Garcea R. L., KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Seminars in Cancer Biology 2009 19 4 270 275 2-s2.0-67349209077 10.1016/j.semcancer.2009.04.001
8. Hirsch H. H., Bowden P., Ljungman P., Snydman D. R., Polyoma and papilloma virus infections after hematopoietic stem cell or solid organ transplantation. Transplant Infections 2010 3rd New York, NY, USA Lippincott Williams & Wilkins 465 482
9. Rinaldo C. H., Traavik T., Hey A., The agnogene of the human polyomavirus BK is expressed. Journal of Virology 1998 72 7 6233 6236 2-s2.0-0031748807 (Pubitemid 28283422)
10. Akan I., Sariyer I. K., Biffi R., Palermo V., Woolridge S., White M. K., Amini S., Khalili K., Safak M., Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology 2006 349 1 66 78 2-s2.0-33745678803 10.1016/j.virol.2006.01.025 (Pubitemid 44255712)
11. Sedman S. A., Good P. J., Mertz J. E., Leader-encoded open reading frames modulate both the absolute and relative rates of synthesis of the virion proteins of simian virus 40. Journal of Virology 1989 63 9 3884 3893 2-s2.0-0024401875 (Pubitemid 19205463)
12. Khalili K., White M. K., Sawa H., Nagashima K., Safak M., The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. Journal of Cellular Physiology 2005 204 1 1 7 2-s2.0-20144370475 10.1002/jcp.20266 (Pubitemid 40776801)
13. Johannessen M., Walquist M., Gerits N., Dragset M., Spang A., Moens U., BKV agnoprotein interacts with alpha-soluble N-ethylmaleimide-sensitive fusion attachment protein, and negatively influences transport of VSVG-EGFP. PLoS One 2011 6 9 e24489
14. Suzuki T., Orba Y., Okada Y., Sunden Y., Kimura T., Tanaka S., Nagashima K., Hall W. W., Sawa H., The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathogens 2010 6 3 2-s2.0-77950444850 10.1371/journal.ppat. 1000801 e1000801
15. Unterstab G., Gosert R., Leuenberger D., Lorentz P., Rinaldo C. H., Hirsch H. H., The polyomavirus BK agnoprotein co-localizes with lipid droplets. Virology 2010 399 2 322 331 2-s2.0-77249139943 10.1016/j.virol.2010.01.011
16. Leuenberger D., Andresen P. A., Gosert R., Binggeli S., Ström E. H., Bodaghi S., Rinaldo C. H., Hirsch H. H., Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored. Clinical and Vaccine Immunology 2007 14 8 959 968 2-s2.0-35248853930 10.1128/CVI.00123-07
17. Bodaghi S., Comoli P., Bösch R., Azzi A., Gosert R., Leuenberger D., Ginevri F., Hirsch H. H., Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. Journal of Clinical Microbiology 2009 47 8 2577 2585 2-s2.0-68549118746 10.1128/JCM.00030-09
18. Binggeli S., Egli A., Schaub S., Binet I., Mayr M., Steiger J., Hirsch H. H., Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. American Journal of Transplantation 2007 7 5 1131 1139 2-s2.0-34247329101 10.1111/j.1600-6143.2007.01754.x (Pubitemid 46643106)
19. Nickeleit V., Hirsch H. H., Zeiler M., Gudat F., Prince O., Thiel G., Mihatsch M. J., BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrology Dialysis Transplantation 2000 15 3 324 332 2-s2.0-0034002940 (Pubitemid 30116466)
20. Beinert D., Neumann L., Uebel S., Tampé R., Structure of the viral TAP-inhibitor ICP47 induced by membrane association. Biochemistry 1997 36 15 4694 4700 2-s2.0-0030994014 10.1021/bi962940v (Pubitemid 27180320)
21. Aisenbrey C., Sizun C., Koch J., Herget M., Abele R., Bechinger B., Tampé R., Structure and dynamics of membrane-associated ICP47, a viral inhibitor of the MHC I antigen-processing machinery. Journal of Biological Chemistry 2006 281 41 30365 30372 2-s2.0-33750064564 10.1074/jbc.M603000200 (Pubitemid 44582092)
22. Galocha B., Hill A., Barnett B. C., Dolan A., Raimondi A., Cook R. F., Brunner J., McGeoch D. J., Ploegh H. L., The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. Journal of Experimental Medicine 1997 185 9 1565 1572 2-s2.0-0030922680 10.1084/jem.185.9.1565 (Pubitemid 27203253)
23. Englert C., Hou X., Maheswaran S., Bennett P., Ngwu C., Re G. G., Garvin A. J., Rosner M. R., Haber D. A., WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. The EMBO Journal 1995 14 19 4662 4675 2-s2.0-0029102956
24. Hansen T. H., Bouvier M., MHC class i antigen presentation: learning from viral evasion strategies. Nature Reviews Immunology 2009 9 7 503 513 2-s2.0-67649842408 10.1038/nri2575
25. Hirsch H. H., Drachenberg C. B., Steiger J., Ramos E., Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management. Advances in Experimental Medicine and Biology 2006 577 160 173 2-s2.0-33745610215 10.1007/0-387-32957-9-11